NHS

• Opinion

The ‘major conditions strategy’: will ministers fail to give cancer the due care and attention it requires?

By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires? By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires?

6 February 2023

• Health & Medicine
• Opinion

Smoking addiction killed my grandfather – now it’s up to the Government to protect my son

According to a new report, England has slipped further off track for its smokefree 2030 goal. Smoking addiction killed my grandfather – it's now up to the Government to protect my son. According to a new report, England has slipped further off track for its smokefree 2030 goal. Smoking addiction killed my grandfather – it's now up to the Government to protect my son.

29 December 2022

• Health & Medicine

Early cancer diagnosis and COVID-19: unpicking the impact of the pandemic

Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future? Cancer diagnosis was clearly hit hard by the pandemic, but the data tells a complicated story. What does it mean for the future?

20 December 2022

• Health & Medicine
• Opinion

The 10-year cancer plan: is improving cancer survival still a priority for this Government?  

Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer. Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer.

8 December 2022

• Health & Medicine

The rise of the ‘long-waiter’ – why cancer waiting times are showing the pressure more than ever before

10 November 2022

• Health & Medicine

NICE doesn’t recommend olaparib for patients with certain prostate cancers

NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective NICE does not recommend olaparib (Lynparza) for people with a type of advanced prostate cancer, as the treatment is not deemed cost-effective

13 September 2022

• Opinion

Opinion: The Government should not be choosing between investing in staff or equipment

As the Conservative leadership campaign continues towards its finale, our next Prime Minister must make cancer a priority As the Conservative leadership campaign continues towards its finale, our next Prime Minister must make cancer a priority

27 July 2022

• Health & Medicine

New reports show staff shortages continue to hold back cancer care

New reports highlight the impact of workforce issues on the ongoing patient backlog and patient outcomes across UK nations.   New reports highlight the impact of workforce issues on the ongoing patient backlog and patient outcomes across UK nations.  

9 June 2022

• Health & Medicine

NHS ‘understaffed and underequipped’ to tackle cancer, say 3 in 4 people

A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer A new poll, carried out by YouGov, has revealed that three quarters of the UK public think the NHS is understaffed and underequipped to tackle cancer

26 May 2022

• Health & Medicine

More than 65,000 people are left waiting to find out if it’s cancer each month

New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month. New calculations from Cancer Research UK estimate that, on average, over 65,000 people in England are left waiting longer than 28 days to find out whether they have cancer each month.

9 May 2022

• Health & Medicine

Reduction in women screened for breast cancer between 2020 and 2021, NHS report finds

A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic. A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.

25 February 2022